1. FRI0176 PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF A REVERSIBLE B CELL INHIBITOR, XMAB®5871, IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE). (June 2019) Authors: Merrill, Joan; June, Joshua; Koumpouras, Fotios; Machua, Wambui; Khan, Mohammad Faisal; Askanase, Anca; Khosroshahi, Arezou; Sheikh, Saira; James, Judith A.; Guthridge, Joel; Rathi, Gaurav; Burington, Bart; Foster, Paul; Zack, Debra Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 761 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Response to: 'Impact of gender on outcomes in ankylosing spondylitis' by Feldtkeller et al. Issue 1 (11th November 2013) Authors: van der Horst-Bruinsma, Irene; Zack, Debra; Szumski, Annette; Koenig, Andrew S Journal: Annals of the rheumatic diseases Issue: Volume 73:Issue 1(2014) Page Start: e3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Rodent Preclinical Models for Developing Novel Antiarthritic Molecules: Comparative Biology and Preferred Methods for Evaluating Efficacy. (28th December 2010) Authors: Bolon, Brad; Stolina, Marina; King, Caroline; Middleton, Scot; Gasser, Jill; Zack, Debra; Feige, Ulrich Other Names: Gualillo Oreste Academic Editor. Journal: Journal of biomedicine and biotechnology Issue: Volume 2011(2011) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗